CYP19A1 and polycystic ovary syndrome: Caldwell et al. [5] revealed that aromatase catalyzes the rate-determining step during the biosynthesis of estrogens from androgens, and disturbances in the secretion and metabolism of estrogens and androgens could be linked to decreased aromatase activity resulting in polycystic ovaries.